Company: GEHC
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001628280-25-017240
Chunk: 44

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 44
---
|:-------|
| Imaging Organic revenue(2)($M)  |     | 50 | %      |     | $ | 10,312 |           |     | $ | 11,088 |         |     | $ | 11,864 |         |     | $ | 10,510 |                          |    |     | 63 | %      |     | 62 | %       |           | 83 | % |            | 5 | % |          | 5 | % |     | 80 | %      |
| Imaging Adjusted EBIT(2)(3)($M) |     | 30 | %      |     | $ |  1,243 |           |     | $ |  1,462 |         |     | $ |  1,681 |         |     | $ |  1,264 |                          | -3 |     | 55 | %      |     |    |         |           |    |   |            |   |   |          |   |   |     |    |        |
| Imaging Inventory Turns         |     | 20 | %      |     |   |    3.3 |           |     |   |    4.4 |         |     |   |    5.3 |         |     |   |        |                      3.7 |    |     | 68 | %      |     |    |         |           |    |   |            |   |   |          |   |   |     |    |        |

(1) Targets and actuals for Imaging included Image Guided Therapies for 2024.

(2) Non-GAAP financial measures. See the Appendix for additional information and definitions of the non-GAAP financial measures used in the Bonus Plan.

(3) Adjusted to exclude $3M for the impact of one 2024 acquisition.

How NEO Bonus Payouts Were Determined. As shown below, in the first quarter of 2025, the Compensation Committee approved 2024 Bonus Plan payouts for our NEOs, which were determined based on the achievement of performance goals at the corporate, and, for Mr. Rott, segment level and individual performance multipliers. For Mr. Arduini, the Compensation Committee approved an individual performance multiplier of 105%. Mr. Arduini had no role in the determination of his bonus. For Messrs. Saccaro, Kass